SAN FRANCISCO, Sept. 1, 2023 /PRNewswire/ — The U.S. Health & Human Services Department (HHS) recommendation to reschedule cannabis from a Schedule I to a Schedule III drug1 will transform the cannabis industry and create new opportunities for banking and financial services providers….
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.